bluebird bio (BLUE) Initiates Restructuring to Reduce Operating Expenses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- Matador Resources to acquire Paloma Permian for $1.275B
bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US
April 5, 2022 7:00 AM EDTExpected to deliver up to $160 million in cost savings over the next two years and extend the Companys cash runway through pivotal upcoming milestones in the first half of 2023
Management team to host conference call today, April 5, 2022 at 8:00 am ET
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Following a review of its strategic priorities,... More
